Literature DB >> 8689686

The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.

C Porcher1, W Swat, K Rockwell, Y Fujiwara, F W Alt, S H Orkin.   

Abstract

The T cell leukemia oncoprotein SCL/tal-1, a basic-helix-loop-helix transcription factor, is required for production of embryonic red blood cells in the mouse yolk sac. To define roles in other lineages, we studied the hematopoietic potential of homozygous mutant SCL/tal-1 -/- embryonic stem cells upon in vitro differentiation and in vivo in chimeric mice. Here we show that in the absence of SCL/tal-1, hematopoiesis, Including the generation of red cells, myeloid cells, megakaryocytes, mast cells, and both T and B lymphoid cells, is undetectable. These findings suggest that SCL/tal-1 functions very early in hematopoietic development, either in specification of ventral mesoderm to a blood cell fate, or in formation or maintenance of immature progenitors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689686     DOI: 10.1016/s0092-8674(00)80076-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  199 in total

1.  Long-range comparison of human and mouse SCL loci: localized regions of sensitivity to restriction endonucleases correspond precisely with peaks of conserved noncoding sequences.

Authors:  B Göttgens; J G Gilbert; L M Barton; D Grafham; J Rogers; D R Bentley; A R Green
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

Review 2.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages.

Authors:  Shireen Saleque; Scott Cameron; Stuart H Orkin
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

4.  Isolation and characterization of the activated B-cell factor 1 homolog in Caenorhabditis elegans.

Authors:  L Nguyen; J Round; R O'Connell; P Geurts; M Funes-Duran; J Wong; G Jongeward; C A Vierra
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

5.  Transcriptional regulation of the stem cell leukemia gene (SCL)--comparative analysis of five vertebrate SCL loci.

Authors:  Berthold Göttgens; Linda M Barton; Michael A Chapman; Angus M Sinclair; Bjarne Knudsen; Darren Grafham; James G R Gilbert; Jane Rogers; David R Bentley; Anthony R Green
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

6.  Translational control of SCL-isoform expression in hematopoietic lineage choice.

Authors:  Cornelis F Calkhoven; Christine Muller; Richard Martin; Goradz Krosl; Hubertus Pietsch; Trang Hoang; Achim Leutz
Journal:  Genes Dev       Date:  2003-04-15       Impact factor: 11.361

7.  Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Duncan T Odom; Jennifer O'Neil; Adolfo A Ferrando; Adam Margolin; Donna S Neuberg; Stuart S Winter; Richard S Larson; Wei Li; X Shirley Liu; Richard A Young; A Thomas Look
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

8.  HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells.

Authors:  Yaxu Wu; Martin Moser; Victoria L Bautch; Cam Patterson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5.

Authors:  Michael Kyba; Rita C R Perlingeiro; Russell R Hoover; Chi-Wei Lu; Jonathan Pierce; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

10.  SRY induced TCF21 genome-wide targets and cascade of bHLH factors during Sertoli cell differentiation and male sex determination in rats.

Authors:  Ramji K Bhandari; Ellyn N Schinke; Md M Haque; Ingrid Sadler-Riggleman; Michael K Skinner
Journal:  Biol Reprod       Date:  2012-12-06       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.